Clinical implications of zolbetuximab-associated hypoalbuminemia in CLDN18.2-positive gastric or gastroesophageal junction cancer

ESMO Gastrointestinal Oncology · Elsevier

Аннотация

Publication date: September 2026 Source: ESMO Gastrointestinal Oncology, Volume 13, Part B Author(s): A. Ooki, K. Shimozaki, S. Fukuoka, S. Udagawa, K. Yoshino, K. Yoshikawa, T. Wakatsuki, M. Ogura, E. Shinozaki, K. Chin, K. Yamaguchi

Читать у издателя →

Похожие статьи